THEUER CHARLES - Insider Non-Derivative Transactions at Tracon Pharmaceuticals, Inc. (TCON) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 20, 2023, THEUER CHARLES's relationship to Tracon Pharmaceuticals, Inc. (TCON) is Director,Officer (PRESIDENT AND CEO), and currently has 406,417 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TCON insiders.
Data Source: SEC.
THEUER CHARLES - Insider Non-Derivative Transactions of TCON Common Stock
THEUER CHARLES - Insider Non-Derivative Transactions at TCON
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 21, 2023 | Acquisition -- (Common Stock) | 3500 | 0.13 | 406417 |
| Apr 28, 2023 | P -- (Common Stock) | 47000 | 0.75 | 399417 |
| Apr 27, 2023 | P -- (Common Stock) | 3999 | 0.66 | 352417 |
| Apr 21, 2023 | Acquisition -- (Common Stock) | 3500 | 0.14 | 402917 |
| Mar 2, 2023 | P -- (Common Stock) | 4800 | 1.52 | 344918 |
| Mar 1, 2023 | P -- (Common Stock) | 200 | 1.52 | 340118 |
| Jan 19, 2023 | P -- (Common Stock) | 6800 | 1.62 | 339918 |